- Home
- IPSC vs ABLV Comparison
IPSC vs ABLV Comparison
Compare IPSC & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- ABLV
- Stock Information
- Founded
- IPSC 2019
- ABLV 2015
- Country
- IPSC United States
- ABLV China
- Employees
- IPSC N/A
- ABLV N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- ABLV
- Sector
- IPSC Health Care
- ABLV
- Exchange
- IPSC Nasdaq
- ABLV Nasdaq
- Market Cap
- IPSC 47.4M
- ABLV 48.6M
- IPO Year
- IPSC 2021
- ABLV N/A
- Fundamental
- Price
- IPSC $0.59
- ABLV $1.04
- Analyst Decision
- IPSC Strong Buy
- ABLV
- Analyst Count
- IPSC 5
- ABLV 0
- Target Price
- IPSC $3.33
- ABLV N/A
- AVG Volume (30 Days)
- IPSC 1.0M
- ABLV 8.1K
- Earning Date
- IPSC 08-07-2025
- ABLV 04-23-2025
- Dividend Yield
- IPSC N/A
- ABLV N/A
- EPS Growth
- IPSC N/A
- ABLV N/A
- EPS
- IPSC N/A
- ABLV N/A
- Revenue
- IPSC $114,898,000.00
- ABLV $128,932,647.00
- Revenue This Year
- IPSC $1,590.09
- ABLV N/A
- Revenue Next Year
- IPSC N/A
- ABLV N/A
- P/E Ratio
- IPSC N/A
- ABLV N/A
- Revenue Growth
- IPSC 8286.72
- ABLV N/A
- 52 Week Low
- IPSC $0.34
- ABLV $0.55
- 52 Week High
- IPSC $3.29
- ABLV $1.90
- Technical
- Relative Strength Index (RSI)
- IPSC 55.59
- ABLV 53.00
- Support Level
- IPSC $0.59
- ABLV $0.84
- Resistance Level
- IPSC $0.57
- ABLV $1.13
- Average True Range (ATR)
- IPSC 0.04
- ABLV 0.06
- MACD
- IPSC 0.00
- ABLV 0.00
- Stochastic Oscillator
- IPSC 66.59
- ABLV 68.97
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.